Evidence map›Paper›PMID 38678564›Full record

ArticleCell reports2024

Independent compartmentalization of functional, metabolic, and transcriptional maturation of hiPSC-derived cardiomyocytes.

K Ashley Fetterman, Malorie Blancard, Davi M Lyra-Leite, Carlos G Vanoye, Hananeh Fonoudi, Mariam Jouni, Jean-Marc L DeKeyser, Brian Lenny, Yadav Sapkota, Alfred L George and 1 more

Abstract read
In one paragraph

Article in Cell reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

K Ashley FettermanDepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA; Center for Pharmacogenomics, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Malorie BlancardDepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA; Center for Pharmacogenomics, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Davi M Lyra-LeiteDepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA; Center for Pharmacogenomics, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Carlos G VanoyeDepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Hananeh FonoudiDepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA; Center for Pharmacogenomics, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Mariam JouniDepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA; Center for Pharmacogenomics, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Jean-Marc L DeKeyserDepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA; Center for Pharmacogenomics, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Brian LennyDepartment of Epidemiology and Cancer Control, St. Jude Children's Hospital, Memphis, TN, USA.
Yadav SapkotaDepartment of Epidemiology and Cancer Control, St. Jude Children's Hospital, Memphis, TN, USA.
Alfred L GeorgeDepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA; Center for Pharmacogenomics, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Paul W BurridgeDepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA; Center for Pharmacogenomics, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. Electronic address: paul.burridge@northwestern.edu.

Funding

Predicting and Preventing Chemotherapy-InducedCardiotoxicity in African American ChildrenR01CA261898 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI BURRIDGE, PAUL W., SAPKOTA, YADAV · 2021 to 2025
$3.6M
Genomic Prediction of Doxorubicin-Induced CardiotoxicityR01CA220002 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI BURRIDGE, PAUL W., STRANGER, BARBARA E · 2018 to 2022
$1.8M
SyncroPatch 384 Automated Patch Clamp InstrumentS10OD034362 · OD · NORTHWESTERN UNIVERSITY · PI GEORGE, ALFRED L. · 2023 to 2023
$599k
CardioExcyte 96 system for pharmacology research at Northwestern UniversityS10OD026867 · OD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GEORGE, ALFRED L. · 2020 to 2020
$162k
NCI NIH HHS R01 CA220002NCI NIH HHS R01 CA261898NIH HHS S10 OD026867NIH HHS S10 OD034362
6 · The paper itself

Abstract

Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) recapitulate numerous disease and drug response phenotypes, but cell immaturity may limit their accuracy and fidelity as a model system. Cell culture medium modification is a common method for enhancing maturation, yet prior studies have used complex media with little understanding of individual component contribution, which may compromise long-term hiPSC-CM viability. Here, we developed high-throughput methods to measure hiPSC-CM maturation, determined factors that enhanced viability, and then systematically assessed the contribution of individual maturation medium components. We developed a medium that is compatible with extended culture. We discovered that hiPSC-CM maturation can be sub-specified into electrophysiological/EC coupling, metabolism, and gene expression and that induction of these attributes is largely independent. In this work, we establish a defined baseline for future studies of cardiomyocyte maturation. Furthermore, we provide a selection of medium formulae, optimized for distinct applications and priorities, that promote measurable attributes of maturation.

Indexed as

Cell DifferentiationInduced Pluripotent Stem CellsMyocytes, CardiacCell Culture TechniquesCells, CulturedCulture MediaHumansTranscription, GeneticCulture MediaCa(2+) transientscardiomyocytesCP: Stem cell researchimpedanceinduced pluripotent stem cellsmaturationviability

Identifiers

PMID38678564
PMCPMC11247623

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.